Skip to main content
. 2016 Nov 17;28(4):1296–1305. doi: 10.1681/ASN.2016040407

Figure 3.

Figure 3.

Relative change in residual albuminuria compared with RS + placebo in the intention-to-treat analysis. The percentage change is shown as individual data with median and interquartile range; data for one participant with extreme values (+259%, −61%, and +165%, respectively) are not shown.